合并嚴(yán)重內(nèi)外科疾病產(chǎn)婦剖宮產(chǎn)的麻醉管理
發(fā)布時間:2018-06-27 14:56
本文選題:嚴(yán)重內(nèi)外科疾病 + 產(chǎn)婦 ; 參考:《中國現(xiàn)代醫(yī)生》2016年32期
【摘要】:目的研究合并嚴(yán)重內(nèi)外科疾病產(chǎn)婦剖宮產(chǎn)的麻醉管理。方法檢索我院2006年6月~2015年6月23例合并嚴(yán)重內(nèi)外科疾病產(chǎn)婦的剖宮產(chǎn)麻醉過程資料,并對其進行分析研究。結(jié)果除1例死亡外,其余產(chǎn)婦在嚴(yán)密監(jiān)測和血管活性藥物的支持下,圍手術(shù)期MAP、HR、CVP和SpO_2基本穩(wěn)定。合并內(nèi)外科疾病對新生兒1 min評分有明顯影響,而5 min評分4分及以下比例為0,說明經(jīng)新生兒復(fù)蘇后無嚴(yán)重抑制。結(jié)論合并嚴(yán)重內(nèi)外科疾病的產(chǎn)婦行剖宮產(chǎn)時,術(shù)中出現(xiàn)產(chǎn)婦死亡、并發(fā)癥及新生兒不良事件的可能性增加,必須在圍麻醉期對患者進行嚴(yán)密監(jiān)測、治療和調(diào)控,盡可能降低產(chǎn)婦的死亡率和并發(fā)癥的發(fā)生率。
[Abstract]:Objective to study the anesthetic management of cesarean section in parturient with severe internal and surgical diseases. Methods data of 23 cases of cesarean section in our hospital from June 2006 to June 2015 were searched and analyzed. Results except for one death, the other puerperas were closely monitored and supported by vasoactive drugs, and the CVP and SpO-2 were stable in perioperative period. The combined internal and surgical diseases had a significant effect on the neonatal 1 min score, while the 5 min score of 4 or below was 0, indicating that there was no serious inhibition after neonatal resuscitation. Conclusion during cesarean section, maternal death, complications and adverse neonatal events are more likely to occur during cesarean section in women with severe medical and surgical diseases. It is necessary to closely monitor, treat and control the patients during the perianaesthesia period. Minimize maternal mortality and the incidence of complications.
【作者單位】: 福建醫(yī)科大學(xué)附屬龍巖第一醫(yī)院麻醉科;
【分類號】:R614
【相似文獻(xiàn)】
相關(guān)期刊論文 前2條
1 王號;王洋;;中醫(yī)入門話疼痛[J];生命世界;2014年03期
2 ;[J];;年期
,本文編號:2074288
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2074288.html
最近更新
教材專著